nodes	percent_of_prediction	percent_of_DWPC	metapath
L-DOPA—DRD3—autistic disorder	0.346	0.505	CbGaD
L-DOPA—DRD1—autistic disorder	0.34	0.495	CbGaD
L-DOPA—DRD3—telencephalic ventricle—autistic disorder	0.00773	0.062	CbGeAlD
L-DOPA—DDC—telencephalic ventricle—autistic disorder	0.00753	0.0604	CbGeAlD
L-DOPA—PSIP1—hindbrain—autistic disorder	0.00624	0.05	CbGeAlD
L-DOPA—DRD1—telencephalic ventricle—autistic disorder	0.00554	0.0444	CbGeAlD
L-DOPA—SLC7A8—mouth—autistic disorder	0.00361	0.0289	CbGeAlD
L-DOPA—PSIP1—brainstem—autistic disorder	0.00358	0.0287	CbGeAlD
L-DOPA—DDC—hindbrain—autistic disorder	0.00356	0.0285	CbGeAlD
L-DOPA—PSIP1—eye—autistic disorder	0.00348	0.0279	CbGeAlD
L-DOPA—PSIP1—forebrain—autistic disorder	0.00345	0.0277	CbGeAlD
L-DOPA—DRD2—telencephalic ventricle—autistic disorder	0.00327	0.0262	CbGeAlD
L-DOPA—PSIP1—telencephalon—autistic disorder	0.00317	0.0255	CbGeAlD
L-DOPA—PSIP1—digestive system—autistic disorder	0.00242	0.0194	CbGeAlD
L-DOPA—L-Tryptophan—TDO2—autistic disorder	0.00238	0.289	CrCbGaD
L-DOPA—SLC7A8—forebrain—autistic disorder	0.00227	0.0182	CbGeAlD
L-DOPA—SLC7A8—telencephalon—autistic disorder	0.00209	0.0168	CbGeAlD
L-DOPA—DDC—brainstem—autistic disorder	0.00204	0.0164	CbGeAlD
L-DOPA—PSIP1—head—autistic disorder	0.00198	0.0158	CbGeAlD
L-DOPA—DDC—forebrain—autistic disorder	0.00197	0.0158	CbGeAlD
L-DOPA—DRD5—forebrain—autistic disorder	0.00189	0.0152	CbGeAlD
L-DOPA—PSIP1—nervous system—autistic disorder	0.00187	0.015	CbGeAlD
L-DOPA—DDC—telencephalon—autistic disorder	0.00181	0.0145	CbGeAlD
L-DOPA—PSIP1—central nervous system—autistic disorder	0.0018	0.0145	CbGeAlD
L-DOPA—L-Tryptophan—TPH2—autistic disorder	0.0018	0.219	CrCbGaD
L-DOPA—SLC7A5—eye—autistic disorder	0.00178	0.0143	CbGeAlD
L-DOPA—PSIP1—cerebellum—autistic disorder	0.00176	0.0141	CbGeAlD
L-DOPA—DRD5—telencephalon—autistic disorder	0.00174	0.014	CbGeAlD
L-DOPA—SLC7A5—telencephalon—autistic disorder	0.00162	0.013	CbGeAlD
L-DOPA—DRD2—hindbrain—autistic disorder	0.00154	0.0124	CbGeAlD
L-DOPA—DRD1—brainstem—autistic disorder	0.0015	0.012	CbGeAlD
L-DOPA—DRD1—forebrain—autistic disorder	0.00145	0.0116	CbGeAlD
L-DOPA—PSIP1—brain—autistic disorder	0.00143	0.0115	CbGeAlD
L-DOPA—DRD1—telencephalon—autistic disorder	0.00133	0.0107	CbGeAlD
L-DOPA—SLC7A8—head—autistic disorder	0.0013	0.0104	CbGeAlD
L-DOPA—SLC7A5—digestive system—autistic disorder	0.00124	0.00992	CbGeAlD
L-DOPA—SLC7A8—nervous system—autistic disorder	0.00123	0.0099	CbGeAlD
L-DOPA—DRD4—brain—autistic disorder	0.00119	0.00956	CbGeAlD
L-DOPA—SLC7A8—central nervous system—autistic disorder	0.00119	0.00953	CbGeAlD
L-DOPA—SLC7A8—cerebellum—autistic disorder	0.00116	0.00932	CbGeAlD
L-DOPA—DRD3—head—autistic disorder	0.00116	0.00927	CbGeAlD
L-DOPA—DDC—head—autistic disorder	0.00113	0.00904	CbGeAlD
L-DOPA—DRD3—nervous system—autistic disorder	0.0011	0.00879	CbGeAlD
L-DOPA—DRD5—head—autistic disorder	0.00108	0.00869	CbGeAlD
L-DOPA—DDC—nervous system—autistic disorder	0.00107	0.00857	CbGeAlD
L-DOPA—DRD3—central nervous system—autistic disorder	0.00106	0.00846	CbGeAlD
L-DOPA—DDC—central nervous system—autistic disorder	0.00103	0.00825	CbGeAlD
L-DOPA—DRD5—nervous system—autistic disorder	0.00103	0.00824	CbGeAlD
L-DOPA—SLC15A1—digestive system—autistic disorder	0.00103	0.00824	CbGeAlD
L-DOPA—SLC7A5—head—autistic disorder	0.00101	0.00809	CbGeAlD
L-DOPA—DRD5—central nervous system—autistic disorder	0.000989	0.00793	CbGeAlD
L-DOPA—SLC7A5—nervous system—autistic disorder	0.000957	0.00767	CbGeAlD
L-DOPA—SLC7A8—brain—autistic disorder	0.000944	0.00757	CbGeAlD
L-DOPA—CYP2D6—hindbrain—autistic disorder	0.000928	0.00744	CbGeAlD
L-DOPA—SLC7A5—central nervous system—autistic disorder	0.000921	0.00739	CbGeAlD
L-DOPA—SLC7A5—cerebellum—autistic disorder	0.0009	0.00722	CbGeAlD
L-DOPA—DRD2—brainstem—autistic disorder	0.000885	0.0071	CbGeAlD
L-DOPA—DRD2—eye—autistic disorder	0.000862	0.00691	CbGeAlD
L-DOPA—DRD2—forebrain—autistic disorder	0.000854	0.00685	CbGeAlD
L-DOPA—DRD3—brain—autistic disorder	0.000838	0.00672	CbGeAlD
L-DOPA—DRD1—head—autistic disorder	0.000828	0.00664	CbGeAlD
L-DOPA—DDC—brain—autistic disorder	0.000816	0.00655	CbGeAlD
L-DOPA—DRD2—telencephalon—autistic disorder	0.000785	0.0063	CbGeAlD
L-DOPA—DRD5—brain—autistic disorder	0.000785	0.0063	CbGeAlD
L-DOPA—DRD1—nervous system—autistic disorder	0.000785	0.0063	CbGeAlD
L-DOPA—DRD1—central nervous system—autistic disorder	0.000756	0.00606	CbGeAlD
L-DOPA—SLC7A5—brain—autistic disorder	0.000731	0.00587	CbGeAlD
L-DOPA—SLC16A10—cerebellum—autistic disorder	0.000689	0.00553	CbGeAlD
L-DOPA—Isoprenaline—MAPK1—autistic disorder	0.000642	0.0779	CrCbGaD
L-DOPA—DRD1—brain—autistic disorder	0.0006	0.00481	CbGeAlD
L-DOPA—CYP2D6—brainstem—autistic disorder	0.000532	0.00427	CbGeAlD
L-DOPA—Methyldopa—COMT—autistic disorder	0.000529	0.0643	CrCbGaD
L-DOPA—CYP2D6—forebrain—autistic disorder	0.000513	0.00412	CbGeAlD
L-DOPA—DRD2—head—autistic disorder	0.000489	0.00392	CbGeAlD
L-DOPA—CYP2D6—telencephalon—autistic disorder	0.000472	0.00379	CbGeAlD
L-DOPA—DRD2—nervous system—autistic disorder	0.000464	0.00372	CbGeAlD
L-DOPA—DRD2—central nervous system—autistic disorder	0.000446	0.00358	CbGeAlD
L-DOPA—DRD2—cerebellum—autistic disorder	0.000436	0.0035	CbGeAlD
L-DOPA—Isoetarine—ADRB2—autistic disorder	0.000387	0.047	CrCbGaD
L-DOPA—Masoprocol—CYP19A1—autistic disorder	0.000375	0.0455	CrCbGaD
L-DOPA—CYP2D6—digestive system—autistic disorder	0.00036	0.00289	CbGeAlD
L-DOPA—DRD2—brain—autistic disorder	0.000354	0.00284	CbGeAlD
L-DOPA—CYP2D6—head—autistic disorder	0.000294	0.00236	CbGeAlD
L-DOPA—CYP2D6—nervous system—autistic disorder	0.000279	0.00223	CbGeAlD
L-DOPA—Dopamine—MAOB—autistic disorder	0.000278	0.0338	CrCbGaD
L-DOPA—CYP2D6—central nervous system—autistic disorder	0.000268	0.00215	CbGeAlD
L-DOPA—CYP2D6—cerebellum—autistic disorder	0.000262	0.0021	CbGeAlD
L-DOPA—Dopamine—COMT—autistic disorder	0.000259	0.0314	CrCbGaD
L-DOPA—CYP2D6—brain—autistic disorder	0.000213	0.00171	CbGeAlD
L-DOPA—Dopamine—MAOA—autistic disorder	0.000195	0.0237	CrCbGaD
L-DOPA—Dopamine—DRD3—autistic disorder	0.000181	0.0219	CrCbGaD
L-DOPA—Dopamine—DRD1—autistic disorder	0.000177	0.0215	CrCbGaD
L-DOPA—Droxidopa—ADRB2—autistic disorder	0.000177	0.0215	CrCbGaD
L-DOPA—Isoprenaline—ADRB2—autistic disorder	0.000161	0.0195	CrCbGaD
L-DOPA—Aminosalicylic Acid—PTGS2—autistic disorder	0.00016	0.0195	CrCbGaD
L-DOPA—Norepinephrine—ADRB2—autistic disorder	0.000149	0.0181	CrCbGaD
L-DOPA—Epinephrine—ADRB2—autistic disorder	0.000135	0.0164	CrCbGaD
L-DOPA—Mesalazine—PTGS2—autistic disorder	0.000126	0.0153	CrCbGaD
L-DOPA—Dopamine—SLC6A4—autistic disorder	0.000126	0.0153	CrCbGaD
L-DOPA—DRD3—Signaling by GPCR—PLA2G4A—autistic disorder	1.51e-05	8.3e-05	CbGpPWpGaD
L-DOPA—DRD4—Signaling by GPCR—HTR2A—autistic disorder	1.5e-05	8.27e-05	CbGpPWpGaD
L-DOPA—CYP2D6—Metabolism—ASMT—autistic disorder	1.49e-05	8.23e-05	CbGpPWpGaD
L-DOPA—CYP2D6—Metabolism—GSTM5—autistic disorder	1.49e-05	8.23e-05	CbGpPWpGaD
L-DOPA—DRD1—GPCR downstream signaling—HTR2A—autistic disorder	1.49e-05	8.2e-05	CbGpPWpGaD
L-DOPA—DRD3—GPCR downstream signaling—HTR2A—autistic disorder	1.47e-05	8.09e-05	CbGpPWpGaD
L-DOPA—DDC—Metabolism—POMC—autistic disorder	1.46e-05	8.05e-05	CbGpPWpGaD
L-DOPA—DRD4—GPCR downstream signaling—PRKCB—autistic disorder	1.45e-05	7.99e-05	CbGpPWpGaD
L-DOPA—DRD4—Signaling Pathways—TSC1—autistic disorder	1.44e-05	7.97e-05	CbGpPWpGaD
L-DOPA—DRD4—Signaling Pathways—DRD1—autistic disorder	1.44e-05	7.97e-05	CbGpPWpGaD
L-DOPA—DRD5—Signaling Pathways—AVP—autistic disorder	1.44e-05	7.96e-05	CbGpPWpGaD
L-DOPA—DRD1—Signaling Pathways—GZMB—autistic disorder	1.44e-05	7.95e-05	CbGpPWpGaD
L-DOPA—DRD5—Signaling Pathways—IGF2—autistic disorder	1.44e-05	7.92e-05	CbGpPWpGaD
L-DOPA—DRD2—GPCR downstream signaling—ADRB2—autistic disorder	1.44e-05	7.92e-05	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—AVPR1A—autistic disorder	1.43e-05	7.87e-05	CbGpPWpGaD
L-DOPA—DRD3—Signaling Pathways—GZMB—autistic disorder	1.42e-05	7.84e-05	CbGpPWpGaD
L-DOPA—DRD4—Signaling Pathways—NTRK2—autistic disorder	1.41e-05	7.75e-05	CbGpPWpGaD
L-DOPA—CYP2D6—Metabolism—SLC25A12—autistic disorder	1.4e-05	7.73e-05	CbGpPWpGaD
L-DOPA—DRD4—Signaling Pathways—DRD3—autistic disorder	1.4e-05	7.72e-05	CbGpPWpGaD
L-DOPA—DRD1—Signaling Pathways—HTR1B—autistic disorder	1.4e-05	7.71e-05	CbGpPWpGaD
L-DOPA—DRD1—Signaling Pathways—OXT—autistic disorder	1.4e-05	7.71e-05	CbGpPWpGaD
L-DOPA—DRD4—GPCR downstream signaling—PIK3CG—autistic disorder	1.39e-05	7.64e-05	CbGpPWpGaD
L-DOPA—DRD3—Signaling Pathways—OXT—autistic disorder	1.38e-05	7.61e-05	CbGpPWpGaD
L-DOPA—DRD3—Signaling Pathways—HTR1B—autistic disorder	1.38e-05	7.61e-05	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—GRM5—autistic disorder	1.38e-05	7.6e-05	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—VIP—autistic disorder	1.38e-05	7.6e-05	CbGpPWpGaD
L-DOPA—DRD4—Signaling Pathways—IL5—autistic disorder	1.37e-05	7.55e-05	CbGpPWpGaD
L-DOPA—CYP2D6—Metabolism—SLC19A1—autistic disorder	1.36e-05	7.52e-05	CbGpPWpGaD
L-DOPA—DRD5—Signaling Pathways—PLA2G4A—autistic disorder	1.36e-05	7.48e-05	CbGpPWpGaD
L-DOPA—DRD4—Signaling Pathways—CALCA—autistic disorder	1.35e-05	7.46e-05	CbGpPWpGaD
L-DOPA—DRD1—Signaling by GPCR—HTR2A—autistic disorder	1.35e-05	7.45e-05	CbGpPWpGaD
L-DOPA—DRD2—GPCR downstream signaling—AVP—autistic disorder	1.35e-05	7.44e-05	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—OXTR—autistic disorder	1.33e-05	7.36e-05	CbGpPWpGaD
L-DOPA—DRD3—Signaling by GPCR—HTR2A—autistic disorder	1.33e-05	7.35e-05	CbGpPWpGaD
L-DOPA—DRD5—GPCR downstream signaling—IL2—autistic disorder	1.32e-05	7.29e-05	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—SCT—autistic disorder	1.32e-05	7.29e-05	CbGpPWpGaD
L-DOPA—DRD5—Signaling Pathways—MEF2C—autistic disorder	1.32e-05	7.28e-05	CbGpPWpGaD
L-DOPA—DRD4—GPCR downstream signaling—POMC—autistic disorder	1.32e-05	7.28e-05	CbGpPWpGaD
L-DOPA—DRD4—Signaling by GPCR—PRKCB—autistic disorder	1.31e-05	7.25e-05	CbGpPWpGaD
L-DOPA—DRD2—Signaling by GPCR—ADRB2—autistic disorder	1.3e-05	7.19e-05	CbGpPWpGaD
L-DOPA—DRD1—GPCR downstream signaling—PRKCB—autistic disorder	1.3e-05	7.19e-05	CbGpPWpGaD
L-DOPA—DRD1—Signaling Pathways—TSC1—autistic disorder	1.3e-05	7.17e-05	CbGpPWpGaD
L-DOPA—DRD2—Circadian rythm related genes—IL6—autistic disorder	1.29e-05	7.12e-05	CbGpPWpGaD
L-DOPA—DRD3—GPCR downstream signaling—PRKCB—autistic disorder	1.29e-05	7.09e-05	CbGpPWpGaD
L-DOPA—DRD5—Signaling Pathways—ITGB3—autistic disorder	1.29e-05	7.09e-05	CbGpPWpGaD
L-DOPA—DRD3—Signaling Pathways—TSC1—autistic disorder	1.28e-05	7.08e-05	CbGpPWpGaD
L-DOPA—DRD3—Signaling Pathways—DRD1—autistic disorder	1.28e-05	7.08e-05	CbGpPWpGaD
L-DOPA—DRD1—Signaling Pathways—NTRK2—autistic disorder	1.26e-05	6.98e-05	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—GABBR1—autistic disorder	1.26e-05	6.95e-05	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—ADM—autistic disorder	1.26e-05	6.95e-05	CbGpPWpGaD
L-DOPA—DRD1—Signaling Pathways—DRD3—autistic disorder	1.26e-05	6.95e-05	CbGpPWpGaD
L-DOPA—DRD4—Signaling by GPCR—PIK3CG—autistic disorder	1.26e-05	6.94e-05	CbGpPWpGaD
L-DOPA—DRD3—Signaling Pathways—NTRK2—autistic disorder	1.25e-05	6.88e-05	CbGpPWpGaD
L-DOPA—DRD1—GPCR downstream signaling—PIK3CG—autistic disorder	1.25e-05	6.88e-05	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—EIF4E—autistic disorder	1.24e-05	6.83e-05	CbGpPWpGaD
L-DOPA—DRD1—Signaling Pathways—IL5—autistic disorder	1.23e-05	6.8e-05	CbGpPWpGaD
L-DOPA—DRD3—GPCR downstream signaling—PIK3CG—autistic disorder	1.23e-05	6.79e-05	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—PDE4B—autistic disorder	1.23e-05	6.77e-05	CbGpPWpGaD
L-DOPA—DRD2—Signaling by GPCR—AVP—autistic disorder	1.23e-05	6.76e-05	CbGpPWpGaD
L-DOPA—DRD1—Signaling Pathways—CALCA—autistic disorder	1.22e-05	6.72e-05	CbGpPWpGaD
L-DOPA—DRD3—Signaling Pathways—IL5—autistic disorder	1.22e-05	6.71e-05	CbGpPWpGaD
L-DOPA—CYP2D6—Metabolism—ADSL—autistic disorder	1.22e-05	6.71e-05	CbGpPWpGaD
L-DOPA—DRD3—Signaling Pathways—CALCA—autistic disorder	1.2e-05	6.63e-05	CbGpPWpGaD
L-DOPA—DRD5—Signaling Pathways—HTR2A—autistic disorder	1.2e-05	6.62e-05	CbGpPWpGaD
L-DOPA—DRD5—Signaling by GPCR—IL2—autistic disorder	1.2e-05	6.62e-05	CbGpPWpGaD
L-DOPA—DRD4—Signaling by GPCR—POMC—autistic disorder	1.2e-05	6.61e-05	CbGpPWpGaD
L-DOPA—DRD4—Signaling Pathways—PRL—autistic disorder	1.19e-05	6.59e-05	CbGpPWpGaD
L-DOPA—CYP2D6—Metabolism—XDH—autistic disorder	1.19e-05	6.58e-05	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—OPRM1—autistic disorder	1.19e-05	6.56e-05	CbGpPWpGaD
L-DOPA—DRD1—GPCR downstream signaling—POMC—autistic disorder	1.19e-05	6.55e-05	CbGpPWpGaD
L-DOPA—DRD1—Signaling by GPCR—PRKCB—autistic disorder	1.18e-05	6.53e-05	CbGpPWpGaD
L-DOPA—DRD3—GPCR downstream signaling—POMC—autistic disorder	1.17e-05	6.46e-05	CbGpPWpGaD
L-DOPA—CYP2D6—Metabolism—STX1A—autistic disorder	1.17e-05	6.46e-05	CbGpPWpGaD
L-DOPA—CYP2D6—Metabolism—NPAS2—autistic disorder	1.17e-05	6.46e-05	CbGpPWpGaD
L-DOPA—DRD3—Signaling by GPCR—PRKCB—autistic disorder	1.17e-05	6.44e-05	CbGpPWpGaD
L-DOPA—DDC—Metabolism—PTGS2—autistic disorder	1.16e-05	6.42e-05	CbGpPWpGaD
L-DOPA—DRD2—Signaling by GPCR—PLA2G4A—autistic disorder	1.15e-05	6.35e-05	CbGpPWpGaD
L-DOPA—DRD5—Signaling Pathways—TSC2—autistic disorder	1.14e-05	6.29e-05	CbGpPWpGaD
L-DOPA—DRD4—Signaling Pathways—ADRB2—autistic disorder	1.13e-05	6.25e-05	CbGpPWpGaD
L-DOPA—DRD1—Signaling by GPCR—PIK3CG—autistic disorder	1.13e-05	6.25e-05	CbGpPWpGaD
L-DOPA—CYP2D6—Metabolism—TCN2—autistic disorder	1.13e-05	6.23e-05	CbGpPWpGaD
L-DOPA—DRD2—GPCR downstream signaling—HTR2A—autistic disorder	1.12e-05	6.19e-05	CbGpPWpGaD
L-DOPA—DRD3—Signaling by GPCR—PIK3CG—autistic disorder	1.12e-05	6.17e-05	CbGpPWpGaD
L-DOPA—DRD5—Signaling Pathways—APOE—autistic disorder	1.12e-05	6.16e-05	CbGpPWpGaD
L-DOPA—DRD5—Signaling Pathways—LEP—autistic disorder	1.12e-05	6.16e-05	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—GZMB—autistic disorder	1.09e-05	6e-05	CbGpPWpGaD
L-DOPA—DRD1—Signaling by GPCR—POMC—autistic disorder	1.08e-05	5.95e-05	CbGpPWpGaD
L-DOPA—CYP2D6—Metabolism—ADA—autistic disorder	1.08e-05	5.95e-05	CbGpPWpGaD
L-DOPA—DRD1—Signaling Pathways—PRL—autistic disorder	1.08e-05	5.93e-05	CbGpPWpGaD
L-DOPA—DRD4—Signaling Pathways—AVP—autistic disorder	1.06e-05	5.87e-05	CbGpPWpGaD
L-DOPA—DRD3—Signaling by GPCR—POMC—autistic disorder	1.06e-05	5.87e-05	CbGpPWpGaD
L-DOPA—DRD3—Signaling Pathways—PRL—autistic disorder	1.06e-05	5.85e-05	CbGpPWpGaD
L-DOPA—DRD4—Signaling Pathways—IGF2—autistic disorder	1.06e-05	5.85e-05	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—HTR1B—autistic disorder	1.06e-05	5.82e-05	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—OXT—autistic disorder	1.06e-05	5.82e-05	CbGpPWpGaD
L-DOPA—DRD5—Signaling Pathways—PRKCB—autistic disorder	1.05e-05	5.81e-05	CbGpPWpGaD
L-DOPA—DRD1—Signaling Pathways—ADRB2—autistic disorder	1.02e-05	5.63e-05	CbGpPWpGaD
L-DOPA—DRD2—Signaling by GPCR—HTR2A—autistic disorder	1.02e-05	5.62e-05	CbGpPWpGaD
L-DOPA—DDC—Metabolism—PTEN—autistic disorder	1.01e-05	5.6e-05	CbGpPWpGaD
L-DOPA—DRD5—Signaling Pathways—APC—autistic disorder	1.01e-05	5.56e-05	CbGpPWpGaD
L-DOPA—DRD5—Signaling Pathways—PIK3CG—autistic disorder	1.01e-05	5.56e-05	CbGpPWpGaD
L-DOPA—DRD3—Signaling Pathways—ADRB2—autistic disorder	1.01e-05	5.55e-05	CbGpPWpGaD
L-DOPA—DRD4—Signaling Pathways—PLA2G4A—autistic disorder	1e-05	5.52e-05	CbGpPWpGaD
L-DOPA—DRD5—Signaling Pathways—EGF—autistic disorder	9.96e-06	5.49e-05	CbGpPWpGaD
L-DOPA—DRD2—GPCR downstream signaling—PRKCB—autistic disorder	9.84e-06	5.43e-05	CbGpPWpGaD
L-DOPA—CYP2D6—Metabolism—RORA—autistic disorder	9.83e-06	5.42e-05	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—TSC1—autistic disorder	9.82e-06	5.41e-05	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—DRD1—autistic disorder	9.82e-06	5.41e-05	CbGpPWpGaD
L-DOPA—DRD4—GPCR downstream signaling—IL2—autistic disorder	9.75e-06	5.38e-05	CbGpPWpGaD
L-DOPA—DRD4—Signaling Pathways—MEF2C—autistic disorder	9.74e-06	5.37e-05	CbGpPWpGaD
L-DOPA—DRD5—Signaling Pathways—POMC—autistic disorder	9.59e-06	5.29e-05	CbGpPWpGaD
L-DOPA—DRD1—Signaling Pathways—AVP—autistic disorder	9.59e-06	5.29e-05	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—NTRK2—autistic disorder	9.55e-06	5.27e-05	CbGpPWpGaD
L-DOPA—DRD1—Signaling Pathways—IGF2—autistic disorder	9.54e-06	5.26e-05	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—DRD3—autistic disorder	9.51e-06	5.24e-05	CbGpPWpGaD
L-DOPA—DRD4—Signaling Pathways—ITGB3—autistic disorder	9.49e-06	5.23e-05	CbGpPWpGaD
L-DOPA—DRD3—Signaling Pathways—AVP—autistic disorder	9.46e-06	5.22e-05	CbGpPWpGaD
L-DOPA—DRD2—GPCR downstream signaling—PIK3CG—autistic disorder	9.42e-06	5.2e-05	CbGpPWpGaD
L-DOPA—DRD3—Signaling Pathways—IGF2—autistic disorder	9.42e-06	5.19e-05	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—IL5—autistic disorder	9.31e-06	5.13e-05	CbGpPWpGaD
L-DOPA—DRD5—Signaling Pathways—IGF1—autistic disorder	9.22e-06	5.09e-05	CbGpPWpGaD
L-DOPA—CYP2D6—Metabolism—MAOB—autistic disorder	9.21e-06	5.08e-05	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—CALCA—autistic disorder	9.19e-06	5.07e-05	CbGpPWpGaD
L-DOPA—DRD5—Signaling by GPCR—MAPK1—autistic disorder	9.18e-06	5.06e-05	CbGpPWpGaD
L-DOPA—DRD1—Signaling Pathways—PLA2G4A—autistic disorder	9.01e-06	4.97e-05	CbGpPWpGaD
L-DOPA—DRD2—GPCR downstream signaling—POMC—autistic disorder	8.97e-06	4.95e-05	CbGpPWpGaD
L-DOPA—DRD2—Signaling by GPCR—PRKCB—autistic disorder	8.94e-06	4.93e-05	CbGpPWpGaD
L-DOPA—DRD3—Signaling Pathways—PLA2G4A—autistic disorder	8.89e-06	4.9e-05	CbGpPWpGaD
L-DOPA—DRD4—Signaling Pathways—HTR2A—autistic disorder	8.86e-06	4.89e-05	CbGpPWpGaD
L-DOPA—DRD4—Signaling by GPCR—IL2—autistic disorder	8.86e-06	4.88e-05	CbGpPWpGaD
L-DOPA—DRD1—GPCR downstream signaling—IL2—autistic disorder	8.78e-06	4.84e-05	CbGpPWpGaD
L-DOPA—DRD1—Signaling Pathways—MEF2C—autistic disorder	8.77e-06	4.84e-05	CbGpPWpGaD
L-DOPA—DRD5—Signaling Pathways—SERPINE1—autistic disorder	8.76e-06	4.83e-05	CbGpPWpGaD
L-DOPA—DRD3—GPCR downstream signaling—IL2—autistic disorder	8.66e-06	4.78e-05	CbGpPWpGaD
L-DOPA—DRD3—Signaling Pathways—MEF2C—autistic disorder	8.65e-06	4.77e-05	CbGpPWpGaD
L-DOPA—CYP2D6—Metabolism—TPH2—autistic disorder	8.57e-06	4.72e-05	CbGpPWpGaD
L-DOPA—DRD2—Signaling by GPCR—PIK3CG—autistic disorder	8.55e-06	4.72e-05	CbGpPWpGaD
L-DOPA—DRD1—Signaling Pathways—ITGB3—autistic disorder	8.54e-06	4.71e-05	CbGpPWpGaD
L-DOPA—DRD3—Signaling Pathways—ITGB3—autistic disorder	8.43e-06	4.65e-05	CbGpPWpGaD
L-DOPA—CYP2D6—Metabolism—DPYD—autistic disorder	8.43e-06	4.65e-05	CbGpPWpGaD
L-DOPA—DRD4—Signaling Pathways—TSC2—autistic disorder	8.42e-06	4.64e-05	CbGpPWpGaD
L-DOPA—DRD4—Signaling Pathways—LEP—autistic disorder	8.24e-06	4.54e-05	CbGpPWpGaD
L-DOPA—DRD4—Signaling Pathways—APOE—autistic disorder	8.24e-06	4.54e-05	CbGpPWpGaD
L-DOPA—DRD2—Signaling by GPCR—POMC—autistic disorder	8.14e-06	4.49e-05	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—PRL—autistic disorder	8.12e-06	4.48e-05	CbGpPWpGaD
L-DOPA—DRD1—Signaling Pathways—HTR2A—autistic disorder	7.98e-06	4.4e-05	CbGpPWpGaD
L-DOPA—DRD1—Signaling by GPCR—IL2—autistic disorder	7.97e-06	4.4e-05	CbGpPWpGaD
L-DOPA—DRD3—Signaling Pathways—HTR2A—autistic disorder	7.87e-06	4.34e-05	CbGpPWpGaD
L-DOPA—DRD3—Signaling by GPCR—IL2—autistic disorder	7.87e-06	4.34e-05	CbGpPWpGaD
L-DOPA—CYP2D6—Metabolism—CACNA1C—autistic disorder	7.83e-06	4.32e-05	CbGpPWpGaD
L-DOPA—DRD4—Signaling Pathways—PRKCB—autistic disorder	7.77e-06	4.28e-05	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—ADRB2—autistic disorder	7.7e-06	4.25e-05	CbGpPWpGaD
L-DOPA—DRD1—Signaling Pathways—TSC2—autistic disorder	7.58e-06	4.18e-05	CbGpPWpGaD
L-DOPA—DRD3—Signaling Pathways—TSC2—autistic disorder	7.48e-06	4.12e-05	CbGpPWpGaD
L-DOPA—DRD4—Signaling Pathways—APC—autistic disorder	7.43e-06	4.1e-05	CbGpPWpGaD
L-DOPA—DRD4—Signaling Pathways—PIK3CG—autistic disorder	7.43e-06	4.1e-05	CbGpPWpGaD
L-DOPA—DRD1—Signaling Pathways—LEP—autistic disorder	7.42e-06	4.09e-05	CbGpPWpGaD
L-DOPA—DRD1—Signaling Pathways—APOE—autistic disorder	7.42e-06	4.09e-05	CbGpPWpGaD
L-DOPA—DRD5—Signaling by GPCR—HRAS—autistic disorder	7.37e-06	4.06e-05	CbGpPWpGaD
L-DOPA—DRD4—Signaling Pathways—EGF—autistic disorder	7.35e-06	4.05e-05	CbGpPWpGaD
L-DOPA—DRD3—Signaling Pathways—LEP—autistic disorder	7.32e-06	4.04e-05	CbGpPWpGaD
L-DOPA—DRD3—Signaling Pathways—APOE—autistic disorder	7.32e-06	4.04e-05	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—AVP—autistic disorder	7.24e-06	3.99e-05	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—IGF2—autistic disorder	7.21e-06	3.97e-05	CbGpPWpGaD
L-DOPA—CYP2D6—Metabolism—DHFR—autistic disorder	7.13e-06	3.93e-05	CbGpPWpGaD
L-DOPA—DRD5—Signaling Pathways—IL2—autistic disorder	7.09e-06	3.91e-05	CbGpPWpGaD
L-DOPA—DRD4—Signaling Pathways—POMC—autistic disorder	7.08e-06	3.9e-05	CbGpPWpGaD
L-DOPA—DRD5—Signaling by GPCR—IL6—autistic disorder	7.05e-06	3.89e-05	CbGpPWpGaD
L-DOPA—DRD1—Signaling Pathways—PRKCB—autistic disorder	6.99e-06	3.86e-05	CbGpPWpGaD
L-DOPA—DRD3—Signaling Pathways—PRKCB—autistic disorder	6.9e-06	3.81e-05	CbGpPWpGaD
L-DOPA—DRD4—Signaling Pathways—IGF1—autistic disorder	6.81e-06	3.75e-05	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—PLA2G4A—autistic disorder	6.8e-06	3.75e-05	CbGpPWpGaD
L-DOPA—DRD4—Signaling by GPCR—MAPK1—autistic disorder	6.77e-06	3.74e-05	CbGpPWpGaD
L-DOPA—DRD1—Signaling Pathways—PIK3CG—autistic disorder	6.69e-06	3.69e-05	CbGpPWpGaD
L-DOPA—DRD1—Signaling Pathways—APC—autistic disorder	6.69e-06	3.69e-05	CbGpPWpGaD
L-DOPA—DRD5—Signaling Pathways—PTEN—autistic disorder	6.67e-06	3.68e-05	CbGpPWpGaD
L-DOPA—DRD2—GPCR downstream signaling—IL2—autistic disorder	6.63e-06	3.66e-05	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—MEF2C—autistic disorder	6.62e-06	3.65e-05	CbGpPWpGaD
L-DOPA—DRD1—Signaling Pathways—EGF—autistic disorder	6.62e-06	3.65e-05	CbGpPWpGaD
L-DOPA—DRD3—Signaling Pathways—APC—autistic disorder	6.6e-06	3.64e-05	CbGpPWpGaD
L-DOPA—DRD3—Signaling Pathways—PIK3CG—autistic disorder	6.6e-06	3.64e-05	CbGpPWpGaD
L-DOPA—DRD3—Signaling Pathways—EGF—autistic disorder	6.53e-06	3.6e-05	CbGpPWpGaD
L-DOPA—DRD4—Signaling Pathways—SERPINE1—autistic disorder	6.46e-06	3.57e-05	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—ITGB3—autistic disorder	6.45e-06	3.56e-05	CbGpPWpGaD
L-DOPA—DRD1—Signaling Pathways—POMC—autistic disorder	6.37e-06	3.51e-05	CbGpPWpGaD
L-DOPA—DRD3—Signaling Pathways—POMC—autistic disorder	6.29e-06	3.47e-05	CbGpPWpGaD
L-DOPA—DRD1—Signaling Pathways—IGF1—autistic disorder	6.13e-06	3.38e-05	CbGpPWpGaD
L-DOPA—DRD1—Signaling by GPCR—MAPK1—autistic disorder	6.1e-06	3.36e-05	CbGpPWpGaD
L-DOPA—DRD3—Signaling Pathways—IGF1—autistic disorder	6.05e-06	3.33e-05	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—HTR2A—autistic disorder	6.02e-06	3.32e-05	CbGpPWpGaD
L-DOPA—DRD2—Signaling by GPCR—IL2—autistic disorder	6.02e-06	3.32e-05	CbGpPWpGaD
L-DOPA—DRD3—Signaling by GPCR—MAPK1—autistic disorder	6.02e-06	3.32e-05	CbGpPWpGaD
L-DOPA—DRD1—Signaling Pathways—SERPINE1—autistic disorder	5.82e-06	3.21e-05	CbGpPWpGaD
L-DOPA—DRD3—Signaling Pathways—SERPINE1—autistic disorder	5.74e-06	3.17e-05	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—TSC2—autistic disorder	5.72e-06	3.16e-05	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—LEP—autistic disorder	5.6e-06	3.09e-05	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—APOE—autistic disorder	5.6e-06	3.09e-05	CbGpPWpGaD
L-DOPA—CYP2D6—Metabolism—CYP19A1—autistic disorder	5.58e-06	3.08e-05	CbGpPWpGaD
L-DOPA—DRD4—Signaling by GPCR—HRAS—autistic disorder	5.44e-06	3e-05	CbGpPWpGaD
L-DOPA—DRD5—Signaling Pathways—MAPK1—autistic disorder	5.42e-06	2.99e-05	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—PRKCB—autistic disorder	5.28e-06	2.91e-05	CbGpPWpGaD
L-DOPA—DRD4—Signaling Pathways—IL2—autistic disorder	5.23e-06	2.89e-05	CbGpPWpGaD
L-DOPA—DRD4—Signaling by GPCR—IL6—autistic disorder	5.21e-06	2.87e-05	CbGpPWpGaD
L-DOPA—CYP2D6—Metabolism—COMT—autistic disorder	5.19e-06	2.86e-05	CbGpPWpGaD
L-DOPA—CYP2D6—Metabolism—GSTP1—autistic disorder	5.17e-06	2.85e-05	CbGpPWpGaD
L-DOPA—CYP2D6—Metabolism—MAOA—autistic disorder	5.15e-06	2.84e-05	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—PIK3CG—autistic disorder	5.05e-06	2.79e-05	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—APC—autistic disorder	5.05e-06	2.79e-05	CbGpPWpGaD
L-DOPA—CYP2D6—Metabolism—CAT—autistic disorder	5.03e-06	2.77e-05	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—EGF—autistic disorder	4.99e-06	2.75e-05	CbGpPWpGaD
L-DOPA—DRD4—Signaling Pathways—PTEN—autistic disorder	4.92e-06	2.71e-05	CbGpPWpGaD
L-DOPA—DRD1—Signaling by GPCR—HRAS—autistic disorder	4.9e-06	2.7e-05	CbGpPWpGaD
L-DOPA—DRD3—Signaling by GPCR—HRAS—autistic disorder	4.83e-06	2.66e-05	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—POMC—autistic disorder	4.81e-06	2.65e-05	CbGpPWpGaD
L-DOPA—CYP2D6—Metabolism—PLA2G4A—autistic disorder	4.75e-06	2.62e-05	CbGpPWpGaD
L-DOPA—CYP2D6—Metabolism—GSTM1—autistic disorder	4.75e-06	2.62e-05	CbGpPWpGaD
L-DOPA—DRD1—Signaling Pathways—IL2—autistic disorder	4.71e-06	2.6e-05	CbGpPWpGaD
L-DOPA—DRD1—Signaling by GPCR—IL6—autistic disorder	4.69e-06	2.58e-05	CbGpPWpGaD
L-DOPA—DRD3—Signaling Pathways—IL2—autistic disorder	4.65e-06	2.56e-05	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—IGF1—autistic disorder	4.63e-06	2.55e-05	CbGpPWpGaD
L-DOPA—DRD3—Signaling by GPCR—IL6—autistic disorder	4.62e-06	2.55e-05	CbGpPWpGaD
L-DOPA—DRD2—Signaling by GPCR—MAPK1—autistic disorder	4.6e-06	2.54e-05	CbGpPWpGaD
L-DOPA—CYP2D6—Metabolism—GPX1—autistic disorder	4.55e-06	2.51e-05	CbGpPWpGaD
L-DOPA—DRD1—Signaling Pathways—PTEN—autistic disorder	4.43e-06	2.44e-05	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—SERPINE1—autistic disorder	4.39e-06	2.42e-05	CbGpPWpGaD
L-DOPA—DRD3—Signaling Pathways—PTEN—autistic disorder	4.37e-06	2.41e-05	CbGpPWpGaD
L-DOPA—DRD5—Signaling Pathways—HRAS—autistic disorder	4.35e-06	2.4e-05	CbGpPWpGaD
L-DOPA—CYP2D6—Metabolism—MTHFR—autistic disorder	4.2e-06	2.31e-05	CbGpPWpGaD
L-DOPA—DRD5—Signaling Pathways—IL6—autistic disorder	4.17e-06	2.3e-05	CbGpPWpGaD
L-DOPA—DRD4—Signaling Pathways—MAPK1—autistic disorder	4e-06	2.21e-05	CbGpPWpGaD
L-DOPA—CYP2D6—Metabolism—APOE—autistic disorder	3.91e-06	2.15e-05	CbGpPWpGaD
L-DOPA—DRD2—Signaling by GPCR—HRAS—autistic disorder	3.7e-06	2.04e-05	CbGpPWpGaD
L-DOPA—DRD1—Signaling Pathways—MAPK1—autistic disorder	3.6e-06	1.99e-05	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—IL2—autistic disorder	3.56e-06	1.96e-05	CbGpPWpGaD
L-DOPA—DRD3—Signaling Pathways—MAPK1—autistic disorder	3.55e-06	1.96e-05	CbGpPWpGaD
L-DOPA—DRD2—Signaling by GPCR—IL6—autistic disorder	3.54e-06	1.95e-05	CbGpPWpGaD
L-DOPA—CYP2D6—Metabolism—PIK3CG—autistic disorder	3.52e-06	1.94e-05	CbGpPWpGaD
L-DOPA—CYP2D6—Metabolism—POMC—autistic disorder	3.36e-06	1.85e-05	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—PTEN—autistic disorder	3.35e-06	1.85e-05	CbGpPWpGaD
L-DOPA—DRD4—Signaling Pathways—HRAS—autistic disorder	3.21e-06	1.77e-05	CbGpPWpGaD
L-DOPA—DRD4—Signaling Pathways—IL6—autistic disorder	3.07e-06	1.7e-05	CbGpPWpGaD
L-DOPA—DRD1—Signaling Pathways—HRAS—autistic disorder	2.89e-06	1.6e-05	CbGpPWpGaD
L-DOPA—DRD3—Signaling Pathways—HRAS—autistic disorder	2.85e-06	1.57e-05	CbGpPWpGaD
L-DOPA—DRD1—Signaling Pathways—IL6—autistic disorder	2.77e-06	1.53e-05	CbGpPWpGaD
L-DOPA—DRD3—Signaling Pathways—IL6—autistic disorder	2.73e-06	1.51e-05	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—MAPK1—autistic disorder	2.72e-06	1.5e-05	CbGpPWpGaD
L-DOPA—CYP2D6—Metabolism—PTGS2—autistic disorder	2.68e-06	1.48e-05	CbGpPWpGaD
L-DOPA—CYP2D6—Metabolism—PTEN—autistic disorder	2.33e-06	1.29e-05	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—HRAS—autistic disorder	2.18e-06	1.2e-05	CbGpPWpGaD
L-DOPA—DRD2—Signaling Pathways—IL6—autistic disorder	2.09e-06	1.15e-05	CbGpPWpGaD
